Generic Name and Formulations:
Hydrogen peroxide 40% w/w; topical soln.
RECENT UPDATESMonograph added.
Indications for ESKATA:
Raised seborrheic keratoses.
For topical application by healthcare provider. Apply 4 times to targeted lesion(s) approx. 1min apart during a single session. May administer another treatment if lesions have not cleared after 3 weeks.
Not for oral, ophthalmic, or intravaginal use. Avoid open or infected seborrheic keratoses, lesions within orbital rim, eyes and mucous membranes.
Erythema, stinging, edema, scaling, crusting, pruritus, vesiculation, erosion, ulceration, hyper/hypopigmentation.
Pen applicator (1.5mL, 2.2mL)—1, 3, 12
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Psychopathology of Adults Affected by Pre- and Perinatal Factors, Family Functioning
- Anxiety: Feature of Late-Onset Dementia or Modifiable Risk Factor?
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- New APA President Takes Office as the First African-American to Lead the Organization
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases
- Exploring the Link Between Persistent Infection, Inflammation, and Mood Disorders
- CDC: No Change in Level of Uninsured in US in 2017
- Benefit of Behavioral Activation During TMS for Major Depressive Disorder
- Global Prevalence of Alcohol, Tobacco, and Illicit Drug Use: A 2017 Status Report